Understanding the Current Rating
The Strong Sell rating indicates a cautious stance towards Riddhi Siddhi Gluco Biols Ltd, signalling that the stock is considered unattractive for investment at present. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s health and market potential.
Quality Assessment
As of 16 May 2026, the company’s quality grade remains below average. This reflects ongoing operational challenges, including persistent losses and weak fundamental strength. The company’s ability to generate sustainable profits is limited, as evidenced by its negative return on capital employed (ROCE) and operating losses. The weak EBIT to interest coverage ratio of -1.04 highlights difficulties in servicing debt, which raises concerns about financial stability and long-term viability.
Valuation Perspective
Currently, Riddhi Siddhi Gluco Biols Ltd is classified as risky from a valuation standpoint. The stock trades at levels that do not adequately compensate investors for the risks involved, particularly given the company’s negative earnings before interest, taxes, depreciation and amortisation (EBITDA) of ₹-7.68 crores. Despite a positive stock return of 14.75% over the past year, the underlying profitability has deteriorated sharply, with profits falling by 75.8%. This disconnect suggests that the market may be pricing in expectations that are not yet supported by fundamentals.
Financial Trend Analysis
The financial trend for Riddhi Siddhi Gluco Biols Ltd is very negative as of today. The company has reported losses for four consecutive quarters, with net sales declining by 9.59%. Profit after tax (PAT) for the nine months ended is ₹22.96 crores, reflecting a steep decline of 70.62%. Meanwhile, interest expenses have surged by 63.25% to ₹13.06 crores, further pressuring profitability. The pre-tax loss excluding other income stands at ₹-10.12 crores, a deterioration of 114.96%. These figures underscore the company’s ongoing operational and financial difficulties.
Technical Outlook
In contrast to the fundamental challenges, the technical grade for the stock is bullish. This suggests that from a price movement perspective, the stock has shown some positive momentum recently. For instance, the stock has gained 31.55% over the past month and 61.13% year-to-date. However, technical strength alone does not offset the underlying financial weaknesses and valuation risks, which remain significant concerns for investors.
Stock Performance Snapshot
As of 16 May 2026, the stock’s recent price movements show mixed signals. While the one-day change was negative at -2.15%, the one-week decline of -11.98% contrasts with strong gains over longer periods: 30.46% over three months and 26.78% over six months. The year-to-date return of 61.13% is notable, yet the one-year return of 14.75% reflects more modest growth. These fluctuations highlight the stock’s volatility and the need for investors to weigh technical trends against fundamental realities.
Implications for Investors
The Strong Sell rating advises investors to exercise caution. The company’s weak fundamentals, risky valuation, and negative financial trends suggest that holding or buying the stock may expose investors to considerable downside risk. While technical indicators show some bullishness, this is insufficient to counterbalance the broader concerns. Investors should carefully consider these factors and monitor developments closely before making investment decisions.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Company Profile and Market Context
Riddhi Siddhi Gluco Biols Ltd operates within the Trading & Distributors sector and is classified as a microcap company. Its modest market capitalisation and sector positioning contribute to its risk profile. The company’s Mojo Score currently stands at 29.0, reflecting the Strong Sell grade, down from a previous score of 39. This score adjustment was made on 01 Feb 2025, signalling a reassessment of the company’s outlook based on evolving fundamentals and market conditions.
Debt and Interest Coverage Concerns
The company’s ability to service its debt remains a critical concern. The negative EBIT to interest coverage ratio of -1.04 indicates that operating earnings are insufficient to cover interest expenses, increasing the risk of financial distress. Rising interest costs, which have grown by over 63% in the past nine months, further strain cash flows and reduce flexibility for operational investments or debt reduction.
Profitability and Sales Trends
Declining net sales by 9.59% and sustained operating losses highlight the challenges in maintaining revenue growth and profitability. The negative EBITDA and shrinking PAT underscore the company’s struggle to generate positive earnings, which is a key factor behind the Strong Sell rating. Investors should be wary of these trends as they indicate ongoing operational inefficiencies and market pressures.
Conclusion: A Cautious Approach Recommended
In summary, Riddhi Siddhi Gluco Biols Ltd’s current Strong Sell rating reflects a combination of weak quality metrics, risky valuation, deteriorating financial trends, and mixed technical signals. While the stock has shown some price strength recently, the fundamental challenges and financial risks outweigh these positives. Investors are advised to approach the stock with caution, considering the potential for further downside and the need for significant improvement in the company’s financial health before reassessing its investment appeal.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
